US Patent Issued to Redux Therapeutics on Oct. 28 for "Compositions comprising inhibitors of microsomal triglyceride transfer protein and Apo-B secretion" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,453,728, issued on Oct. 28, was assigned to Redux Therapeutics LLC (Marblehead, Mass.).

"Compositions comprising inhibitors of microsomal triglyceride transfer protein and Apo-B secretion" was invented by Enoch Kim (Marblehead, Mass.) and Paul Sweetnam (Marblehead, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to pharmaceutical composition(s) comprising particles comprising one or more compounds which are inhibitors of microsomal triglyceride transfer protein and/or apolipoprotein B (Apo B) secretion, wherein at least 50% of the particles are characterized by a volume particle fraction less than 10 micro metre, more ...